FDA Inspection 1231122 — Coriell Institue For Medical Research
The FDA completed an inspection of Coriell Institue For Medical Research on Feb 12, 2024 in Camden, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Camden, NJ (United States)